C1QA and cancer: (38) revealed that C1Q could inhibit the response to self-antigens via altering the mitochondrial metabolism of CD8+ T lymphocytes in systemic lupus erythematosus, and C1Q deficiency may result in fatal immunopathology. While C1QA appears to be expressed differently in cancer.